National Institute on Deafness and Other Communication Disorders (NIDCD)   Report issue

Government Phase 1 Phase 2 Phase 3
Founded: Bethesda MD United States (1988)

Organization Overview

First Clinical Trial
1998
NCT00000361
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

National Institute on Deafness and Other Communication Disorders (NIDCD)